SCPH - Scpharmaceuticals Inc Stock Price, Fair Value and News

$5.67

Market Closed as of 08 Oct 2025, 04:00 pm ET

SCPH Stock Valuation Analysis

Valuation

Max Portfolio %

SCPH Price Action

SCPH RSI Chart

SCPH Stock Valuation Analysis

Valuation

Max Portfolio %

SCPH Valuation

SCPH Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

SCPH Fundamentals

SCPH Revenue

SCPH Earnings

SCPH Profitability

SCPH Investor Care

Revenue & Growth

How Scpharmaceuticals Inc generates revenue and covers its expenses, based on the latest reported earnings.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

Net sales

Year	Q1	Q2	Q3	Q4
2025	42.0M	50.0M	-	-
2024	17.6M	24.0M	30.3M	36.3M
2023	-	-	-	13.6M

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Scpharmaceuticals Inc

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. The company was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

CEO	Mr. John H. Tucker
WEBSITE	scpharmaceuticals.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	96